The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies

Muscle and Nerve

Volumn 24, Issue 12, 2001, Pages 1575-1594

  Rando, Thomas A ^a,b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Apoptosis; Calmodulin; Caveolin; Duchenne muscular dystrophy; Dystrobrevin; Dystroglycan; Dystrophin; Grb2; Integrin; Mdx; Necrosis; Nitric oxide synthase; Phosphorylation; Sarcoglycan; Sarcospan; Signaling; Syntrophin; Utrophin

Indexed keywords

CALMODULIN; CAVEOLIN; DYSTROBREVIN; DYSTROGLYCAN; DYSTROPHIN; GLYCOPROTEIN; INTEGRIN; NITRIC OXIDE SYNTHASE; SARCOGLYCAN; SYNTROPHIN;

APOPTOSIS; CELL DEATH; CELL SURVIVAL; DEFENSE MECHANISM; HUMAN; MOLECULAR INTERACTION; MUSCULAR DYSTROPHY; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL SURVIVAL; DYSTROPHIN; GLYCOPROTEINS; HUMANS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; SIGNAL TRANSDUCTION;

EID: 0035190381     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.1192     Document Type: Review

References (224)

1. Neuronal nitric oxide synthase localizes through multiple structural motifs to the sarcolemma in mouse myotubes
2. Two forms of mouse syntrophin, a 58 kd dystrophin-associated protein, differ in primary structure and tissue distribution
3. Mouse α1- and β2-syntrophin gene structure, chromosome localization, and homology with a discs large domain
4. Absence of α-syntrophin leads to structurally aberrant neuromuscular synapses deficient in utrophin
5. The three human syntrophin genes are expressed in diverse tissues, have distinct chromosomal locations, and each bind to dystrophin and its relatives
6. The structural and functional diversity of dystrophin
7. Syntrophin binds to an alternatively spliced exon of dystrophin
8. Cloning of human basic Al, a distinct 59-kDa dystrophin-associated protein encoded on chromosome 8q23-24
9. Utrophin lacks the rod domain actin binding activity of dystrophin
10. 2+-calmodulin binds to the carboxyl-terminal domain of dystrophin
11. Eye muscle sparing by the muscular dystrophies: Lessons to be learned?
12. Characterization of the tyrosine phosphorylation and distribution of dystrobrevin isoforms
13. Gastric hypomotility in Duchenne's muscular dystrophy
14. Expression of γ-sarcoglycan in smooth muscle and its interaction with the smooth muscle sarcoglycan-sarcospan complex
15. Localization of cranin (dystroglycan) at sites of cell-matrix and cell-cell contact: Recruitment to focal adhesions is dependent upon extracellular ligands
16. Ecto-ATPase activity of α-sarcoglycan (adhalin)
17. Different dystrophin-like complexes are expressed in neurons and glia
18. β-dystrobrevin, a member of the dystrophin-related protein family
19. Isoform diversity of dystrobrevin, the murine 87-kDa postsynaptic protein
20. Utrophin: A structural and functional comparison to dystrophin
21. Apoptosis and necrosis: Two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures
22. Freeze-fracture studies of muscle caveolae in human muscular dystrophy
23. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms
24. Nitric oxide: A physiologic messenger molecule
25. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and al-syntrophin mediated by PDZ domains
26. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy
27. Myotonic dystrophy: Clinical and molecular aspects
28. Dystrophic phenotype induced in vitro by antibody blockade of muscle α-dystroglycan-laminin interaction
29. Nitric oxide (NO): An effector of apoptosis
30. The subcellular distribution of dystrophin in mouse skeletal, cardiac, and smooth muscle
31. Identification of α-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus
32. The dystrophinopathies: An alternative to the structural hypothesis
33. Evidence for in situ and in vitro association between α-dystroglycan and the subsynaptic 43K rapsyns protein. Consequence for acetylcholine receptor clustering at the synapse
34. Integrin-mediated signal transduction pathways
35. Association of the dystroglycan complex isolated from bovine brain synaptosomes with proteins involved in signal transduction
36. Oxidant, mitochondria and calcium: An overview
37. Molecular organization of sarcoglycan complex in mouse myotubes in culture
38. Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy
39. Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy
40. Muscular dystrophy in mdx mice despite lack of neuronal nitric oxide synthase
41. The Grb2 adaptor
42. Dystrophin gene transcribed from different promoters in neuronal and glial cells
43. Pleckstrin homology domain 1 of mouse α1-syntrophin binds phosphatidylinositol 4,5-bisphosphate
44. Laminin-induced clustering of dystroglycan on embryonic muscle cells: Comparison with agrin-induced clustering
45. The search for physiological substrates of MAP and SAP kinases in mammalian cells
46. Molecular basis of muscular dystrophies
47. Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex
48. Secondary reduction of α7 integrin in laminin α2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle
49. Interaction between the nicotinic acetylcholine receptor and Grb2. Implications for signaling at the neuromuscular junction
50. Laminin polymerization induces a receptor-cytoskeleton network
51. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: A novel mechanism for cardiomyopathy and muscular dystrophy
52. Transgenic mdx mice expressing dystrophin with a deletion in the actin-binding domain display a "mild Becker" phenotype
53. Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses
54. Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy
55. Sarcospan, the 25-kDa transmembrane component of the dystrophin-glycoprotein complex
56. Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex
57. Molecular and genetic characterization of sarcospan: Insights into sarcoglycan-sarcospan interactions
58. Mdx muscle pathology is independent of nNOS perturbation
59. Caveolin-3 is not an integral component of the dystrophin glycoprotein complex
60. Muscle development in mdx mutant mice
61. Nitric oxide and oxygen radicals: A question of balance
62. Cellular survival: A play in three Akts
63. Postsynaptic abnormalities at the neuromuscular junctions of utrophin-deficient mice
64. Guanylate cyclase and the NO/cGMP signaling pathway
65. Dystrophin mutations predict cellular susceptibility to oxidative stress
66. Evidence of oxidative stress in mdx mouse muscle: Studies of the pre-necrotic state
67. Integrin-mediated muscle cell spreading. The role of protein kinase C in outside-in and inside-out signaling and evidence of integrin cross-talk
68. Expression of the dystrophin-related protein 2 (Drp2) transcript in the mouse
69. Loss of plasma membrane structural support in ATP-depleted renal epithelia
70. What is muscular dystrophy? Forty years of progressive ignorance
71. Biochemical characterization of the epithelial dystroglycan complex
72. Non-muscle α-dystroglycan is involved in epithelial development
73. Direct binding of Torpedo syntrophin to dystrophin and the 87 kDa dystrophin homologue
74. α-sarcoglycan, a broadly expressed homologue of the gene mutated in limb-girdle muscular dystrophy 2D
75. Increased activity of calcium leak channels in myotubes of Duchenne human and mdx mouse origin
76. Kinases: Positive and negative regulators of apoptosis
77. Critical evaluation of cytosolic calcium determination in resting muscle fibres from normal and dystrophic (mdx) mice
78. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and T-tubule abnormalities
79. Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype
80. Interaction of muscle and brain sodium channels with multiple members of the syntrophin family of dystrophin-associated proteins
81. Dystroglycan-α, a dystrophin-associated glycoprotein, is a functional agrin receptor
82. Dystrobrevin- and dystrophin-like mutants display similar phenotypes in the nematode Caenorhabditis elegans
83. Membrane abnormalities and Ca homeostasis in muscles of the mdx mouse, an animal model of the Duchenne muscular dystrophy: A review
84. Lipid hydroperoxide generation, turnover, and effector action in biological systems
85. A dystrophin missense mutation showing persistence of dystrophin and dystrophin-associated proteins yet a severe phenotype
86. Role for α-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies
87. Subtle neuromuscular defects in utrophin-deficient mice
88. Maturation and maintenance of the neuromuscular synapse: Genetic evidence for roles of the dystrophin-glycoprotein complex
89. Nitric oxide synthase in skeletal muscle fibers: A signaling component of the dystrophin-glycoprotein complex
90. Focal adhesion kinase in integrin signaling
91. Muscle degeneration without mechanical injury in sarcoglycan deficiency
92. γ-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin
93. Dystrophin deficiency, altered cell signalling and fibre hypertrophy
94. Stress-activated protein kinase-3 interacts with the PDZ domain of α1-syntrophin. A mechanism for specific substrate recognition
95. Mutations in the integrin α7 gene cause congenital myopathy
96. Dystroglycan inside and out
97. Distinct roles for dystroglycan, β1 integrin and perlecan in cell surface laminin organization
98. Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy
99. Regulation of reactive oxygen species-induced apoptosis and necrosis by caspase 3-like proteases
100. Altered expression of the alpha7beta1 integrin in human and murine muscular dystrophies
101. Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy, with special reference to mental ability
102. Assembly of the sarcoglycan complex. Insights for muscular dystrophy
103. Biosynthesis of dystroglycan: Processing of a precursor propeptide
104. Integrins: Versatility, modulation, and signaling in cell adhesion
105. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix
106. Human dystroglycan: Skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization
107. A sarcoglycandystroglycan complex anchors Dp116 and utrophin in the peripheral nervous system
108. α1-syntrophin has distinct binding sites for actin and calmodulin
109. α-dystroglycan functions in acetylcholine receptor aggregation but is not a coreceptor for agrin-MuSK signaling
110. Adhesion-dependent tyrosine phosphorylation of Β-dystroglycan regulates its interaction with utrophin
111. Alternate binding of actin and calmodulin to multiple sites on dystrophin
112. Identification and characterization of the dystrophin anchoring site on β-dystroglycan
113. A PDZ-containing scaffold related to the dystrophin complex at the basolateral membrane of epithelial cells
114. α1-syntrophin gene disruption results in the absence of neuronal-type nitricoxide synthase at the sarcolemma but does not induce muscle degeneration
115. The molecular basis for Duchenne versus Becker muscular dystrophy: Correlation of severity with type of deletion
116. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein
117. Interaction of ion channels and receptors with PDZ domain proteins
118. Dystrophin as a focal adhesion protein. Collocalization with talin and the M, 48,000 sarcolemmal protein in cultured Xenopus muscle
119. Association of utrophin and multiple dystrophin short forms with the mammalian M, 58,000 dystrophin-associated protein
120. Mechanisms of cell damage and enzyme release
121. Disruption of the lama2 gene in embryonic stem cells: Laminin α2 is necessary for sustenance of mature muscle cells
122. The α5β1 integrin associates with a dystrophin-containing lattice during muscle development
123. Sarcospandeficient mice maintain normal muscle function
124. Mitochondrial dysfunction in the pathogenesis of necrotic and apoptotic cell death
125. Dp140: Alternatively spliced isoforms in brain and kidney
126. Filamin binds to the cytoplasmic domain of the beta1-integrin. Identification of amino acids responsible for this interaction
127. Tissue distribution of the dystrophin-related gene product and expression in the mdx and dy mouse
128. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling
129. Dystrophin is phosphorylated by endogenous protein kinases
130. Interactions between β2-syntrophin and a family of microtubule-associated serine/threonine kinases
131. Calmodulin-activated phosphorylation of dystrophin
132. Interactions between dystrophin glycoprotein complex proteins
133. 2+-calmodulin dependent protein kinase II
134. Calmodulin specifically binds three proteins of the dystrophin-glycoprotein complex
135. The tetraspanin superfamily: Molecular facilitators
136. Absence of integrin α7 causes a novel form of muscular dystrophy
137. Time course of changes in plasma membrane permeability in the dystrophin-deficient mdx mouse
138. How does dystrophin deficiency lead to muscle degeneration? - Evidence from the mdx mouse
139. Mutations that disrupt the carboxyl-terminus of γ-sarcoglycan cause muscular dystrophy
140. Phosphorylation of the carboxyl-terminal region of dystrophin
141. cdc2 protein kinase
142. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy
143. α-dystroglycan is a laminin receptor involved in extracellular matrix assembly on myotubes and muscle cell viability
144. Oxidative stress and muscular dystrophy
145. 2+binding protein
146. Alternative splicing of dystrobrevin regulates the stoichiometry of syntrophin binding to the dystrophin protein complex
147. Syncoilin, a novel member of the intermediate filament superfamily that interacts with alpha-dystrobrevin in skeletal muscle
148. Elevated calmodulin levels and reduced calmodulinstimulated calcium-ATPase in Duchenne progressive muscular dystrophy
149. Formation of sarcoglycan complex with differentiation in cultured myocytes
150. Complementary distributions of vinculin and dystrophin define two distinct sarcolemma domains in smooth muscle
151. Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice
152. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane
153. The receptor tyrosine phosphatase-like protein ICA512 binds the PDZ domains of β2-syntrophin and nNOS in pancreatic beta-cells
154. From dystrophinopathy to sarcoglycanopathy: Evolution of a concept of muscular dystrophy
155. Facioscapulohumeral muscular dystrophy
156. Differential association of syntrophin pairs with the dystrophin complex
157. β-dystrobrevin, a new member of the dystrophin family. Identification, cloning, and protein associations
158. Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb-girdle muscular dystrophies
159. Dystrophin expression in the human retina is required for normal function as defined by electroretinography
160. Forced expression of dystrophin deletion constructs reveals structure-function correlations
161. Role of α-dystroglycan as a Schwann cell receptor for Mycobacterium leprae
162. The role of nitric oxide in the pathogenesis of muscular dystrophies: A "two hit" hypothesis of the cause of muscle necrosis
163. Muscle cells from mdx mice have an increased susceptibility to oxidative stress
164. The WW domain of dystrophin requires EF-hands region to interact with β-dystroglycan
165. Characterization of file β-dystroglycan-growth factor receptor 2 (Grb2) interaction
166. A new model for the interaction of dystrophin with F-actin
167. Cloning and characterization of the human homologue of a dystrophin related phosphoprotein found at the Torpedo electric organ post-synaptic membrane
168. Dystrobrevin and dystrophin: An interaction through coiled-coil motifs
169. 7 integrin-deficient mice
170. Characterization of the transmembrane molecular architecture of the dystroglycan complex in schwann cells
171. Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy
172. Signaling through focal adhesion kinase
173. Specific interactions between the syntrophin PDZ domain and voltage-gated sodium channels
174. Phosphorylation of dystrophin: Effects on actin binding
175. Interaction of dystrophin with cytoskeletal proteins: Binding to talin and actin
176. The pleckstrin homology domain: An intriguing multifunctional protein module
177. Phosphorylation of the carboxyl terminal region of dystrophin by mitogen-activated protein (MAP) kinase
178. The molecular basis of muscular dystrophy in the mdx mouse: A point mutation
179. Caveolins, liquidordered domains, and signal transduction
180. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains
181. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins
182. Caveolin-3 directly interacts with the C-terminal tail of β-dystroglycan. Identification of a central WW-like domain within caveolin family members
183. +) T cells promote the pathology of dystrophin-deficient muscle
184. Identification of filamin as a novel ligand for caveolin-1: Evidence for the organization of caveolin-l-associated membrane domains by the actin cytoskeleton
185. Cadherins and their connections: Adhesion junctions have broader functions
186. Filamins as integrators of cell mechanics and signalling
187. Mammalian α1- and β1-syntrophin bind to the alternative splice-prone region of the dystrophin COOH terminus
188. Glycoproteinbinding site of dystrophin is confined to the cysteine-rich domain and the first half of the carboxy-terminal domain
189. Dystrophic muscle in mice chimeric for expression of α5 integrin
190. DNA-fragmentation and expression of apoptosis-related proteins in muscular dystrophies
191. Impaired metabolic modulation of α-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle
192. Filamin 2 (FLN2): A muscle-specific sarcoglycan interacting protein
193. Dystroglycan in the cerebellum is a laminin α2-chain binding protein at the glial-vascular interface and is expressed in Purkinje cells
194. Apoptosis precedes necrosis of dystrophin-deficient muscle
195. Primary structure of dystrophin-related protein
196. Increasing complexity of the dystrophin-associated protein complex
197. Redefinition of dystrophin isoform distribution in mouse tissue by RT-PCR implies role in nonmuscle manifestations of Duchenne muscular dystrophy
198. Congenital muscular dystrophies
199. Increased calcium influx in dystrophic muscle
200. Merosin and laminin in myogenesis: Specific requirement for merosin in myotube stability and survival
201. Integrins (α7β1) in muscle function and survival. Disrupted expression in merosindeficient congenital muscular dystrophy
202. Increased caveolin-3 levels in mdx mouse muscles
203. Further evidence for the organisation of the four sarcoglycans proteins within the dystrophin-glycoprotein complex
204. Interaction ofneuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain
205. Characterization of the recombinant C-terminal domain of dystrophin: Phosphorylation by calmodulin-dependent protein kinase and dephosphorylation by type 2-protein phosphatase
206. A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth
207. A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling
208. Dystroglycan is essential for early embryonic development: Disruption of Reichert's membrane in Dag1-null mice
209. Calcium/calmodulindependent regulation of the NH2-terminal F-actin binding domain of utrophin
210. Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide
211. Integrin activation and cytoskeletal interaction are essential for the assembly of a fibronectin matrix
212. Dystroglycan is a binding protein of laminin and merosin in peripheral nerve
213. Heterogeneity of dystrophin-associated proteins
214. SH3 domain-mediated interaction of dystroglycan and Grb2
215. Identification of α-syntrophin binding to syntrophin triplet, dystrophin, and utrophin
216. Embryonic mesodermal defects in α5 integrin-deficient mice
217. Biochemical evidence for association of dystrobrevin with the sarcoglycan-sarcospan complex as a basis for understanding sarcoglycanopathy
218. 3H1 cells and involvement of α-sarcoglycan in substrate attachment
219. Bidirectional signaling between sarcoglycans and the integrin adhesion system in cultured L6 myocytes
220. Dystrophin in control and mdx retina
221. The susceptibility of muscle cells to oxidative stress is independent of nitric oxide synthase expression
222. The syndecans, turners of transmembrane signaling